BioSpace News Archive

Deals

SenesTech, Inc. Informs Stockholders of Key Dates Related to Announced Rights Offering

SenesTech, Inc. provided an informational update to stockholders regarding its rights offering and the key dates and terms relative to the offering.

July 10, 2018
·
4 min read
Policy

BioArctic Receives Regulatory Approval in Finland for a Clinical Study in Patients With Complete Spinal Cord Injury

BioArctic AB announced that the company has received approval by Fimea and Valvira for inclusion of Finnish patients in BioArctic’s ongoing clinical Phase 1/2 study with SC0806.

July 10, 2018
·
5 min read
Biotech Beach

International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products

International Stem Cell Corporation announced today that Lifeline Cell Technology (LCT), has expanded its business and manufacturing capabilities to fulfill current and forecasted demand.

July 10, 2018
·
4 min read
Drug Development

Arbutus Presents Corporate Update on Key Milestones

Arbutus Biopharma Corporation today announced updates on several key milestones in advance of the company’s presentation at Roivant Pipeline Day in New York City this afternoon.

July 10, 2018
·
7 min read
Drug Development

Recursion Receives FDA Clearance of Investigational New Drug Application to Initiate First Clinical Trial of REC-994 in Cerebral Cavernous Malformation

Recursion announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a Phase 1 clinical trial of REC-994 in the treatment of cerebral cavernous malformation (CCM).

July 10, 2018
·
3 min read
Business

Veteran Biopharma Operations Leader Tina M. Larson to Join Recursion as Chief Operating Officer

Recursion announced the company has appointed Tina M. Larson as Chief Operating Officer.

July 10, 2018
·
4 min read
Drug Development

ArmaGen’s AGT-181 52-Week Phase 1/2 Proof-of-Concept Study Results Published in Orphanet Journal of Rare Diseases

Novel Fusion Protein Demonstrates Neurocognitive Benefit in Children with Severe Mucopolysaccharidosis Type I (MPS I, or Hurler Syndrome), with Favorable Safety Profile

July 10, 2018
·
7 min read
Job Trends

Medical Device Startup HeartHero Closes Seed Round Of Funding

Milestone Brings Company One Step Closer to Saving Lives

July 10, 2018
·
2 min read
Business

Avella’s use of AdhereTech improves adherence and generates one to two additional fills per patient per year, across multiple specialty medications and diseases

The specialty pharmacy uses AdhereTech smart pill bottles for multiple specialty medications from various manufacturers, with consistent improvements in adherence, duration, refills, and the patient experience.

July 10, 2018
·
4 min read
Business

Urovant Sciences Appoints Sef Kurstjens and Pierre Legault to its Board of Directors

Urovant Sciences announced the appointments of Sef Kurstjens, M.D., Ph.D. and Pierre Legault to its board of directors.

July 10, 2018
·
4 min read